查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861734

按自动化程度、最终用户、材料类型、包装类型、剂型和服务类型分類的全球医药合约包装市场预测（2025-2032年）

Pharmaceutical Contract Packaging Market by Automation Level, End User, Material Type, Packaging Type, Dosage Form, Service Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，药品合约包装市场将成长至 704.9 亿美元，复合年增长率为 9.21%。

关键市场统计数据
基准年 2024 348.2亿美元
预计年份：2025年 381亿美元
预测年份 2032 704.9亿美元
复合年增长率 (%) 9.21%

将合约包装的策略角色不断演变，定位为在整个製药产品组合中实现产品完整性、合规性和商业性差异化的关键组成部分。

医药合约包装产业在临床供应连续性、品牌保护和法规遵循方面占据着至关重要的地位。近年来，包装已从一种商品化服务演变为确保产品完整性、病患安全和市场差异化的策略要素。随着製造商面临日益复杂的生物製药、组合产品和多元化的全球市场管道，他们的包装合作伙伴必须在不断扩展的材料和包装规格选择范围内，提供精准、可追溯且灵活的包装方案。

探索自动化、数位化可追溯性、材料创新和不断变化的终端用户需求如何融合，从而重新定义合约包装策略和能力。

在整个医药包装产业，变革正在重塑竞争格局和营运重点。从全自动化生产线到半自动化单元，自动化程度的不断提高，在提升产能的同时，减少了人为错误，并加强了污染控制。同时，数位化和序列化技术正在重塑可追溯性能力，实现从填充到分销的即时可视化，并支援更严格的防伪和供应链透明度监管要求。

评估到 2025 年关税趋势对包装业务投入成本、筹资策略、合规负担和资本配置的多方面影响

到了2025年，已宣布或实施的关税累积效应为合约包装业务带来新的成本和策略复杂性。进口原料（包括玻璃、铝、钢和某些塑胶）关税的提高推高了投入成本，迫使包装相关企业重新评估其筹资策略和供应商关係。为此，许多公司加快了双重采购的步伐，将采购转向近岸供应商，并加强谈判，以在遵守受限材料规格的同时保护利润率。

基于全面细分的洞察揭示了自动化、最终用户画像、材料选择、包装、剂型和服务类型如何驱动策略重点和营运设计。

細項分析揭示了合约包装生态系统中价值和风险集中的区域。了解这些层面有助于企业领导者优先考虑投资和伙伴关係。对自动化程度的评估揭示了两种截然不同的营运模式：人工包装，对于某些小批量或高度客製化的产品线仍然至关重要；以及自动化包装，可提供规模化和一致性。在自动化领域，机器人系统可提供最佳的重复性，并为注射剂和易碎品提供无菌区域的优势；而半自动化系统则在灵活性和成本之间取得了更好的平衡，适用于中等批量和二次包装作业。

在美洲、欧洲、中东和非洲以及亚太地区进行区域差异化和能力优先排序，确保能力建构与法规环境和商业性现实相符。

区域趋势正在塑造投资和产能扩张最具战略价值的领域，而稳健的营运需要针对每个区域采取差异化的方法。在美洲，一体化的供应链、大规模的生物製药研发管线以及完善的法规结构，催生了对先进的无菌填充和封装能力、序列化合规性以及强大的二级和三级物流的需求。该地区也为近岸筹资策略提供了机会，这些策略可以降低关税风险，并有助于快速回应市场需求。

策略联盟、垂直整合、专业化以及对品质系统和自动化的投资所驱动的竞争动态，正在推动对多样化药品包装的需求。

整合、策略联盟和能力专业化是主要企业活动中涌现的关键主题。合约包装供应商正越来越多地与原材料供应商、设备供应商和技术公司合作，以加快获得先进的填充、贴标和序列化能力，同时控制资本密集度。这些联盟也有助于快速部署已验证的生物製药和复杂剂型生产线。同时，一些公司正在寻求垂直整合，以获得设计开发、序列化和可追溯性等附加价值服务，而另一些公司则专注于无菌注射剂、低温运输相容性和大批量泡壳包装等细分专业领域，以保持营运效率。

切实可行的双管齐下建议，旨在优化落地成本、加速产品序列化进程、规划自动化投资，同时推动区域扩张和永续性倡议。

产业领导者应采取双轨策略，兼顾短期韧性与长期能力建构。短期内，应优先优化落地成本，具体措施包括：重新设计供应商合同，纳入符合关税规定的条款；尽可能扩大双重采购；以及对优质玻璃替代品和高性能塑料实施材料再认证计划，以评估其稳定性等效性。同时，应加快序列化和追踪系统的实施，这些系统不仅要满足监管要求，还要提供营运可视性，从而减少召回，提高退货处理效率。

为了确保研究结果具有可操作性和有效性，我们采用了稳健的混合方法研究设计，整合了主要行业访谈、监管和技术审查、情境映射以及迭代专家检验。

本研究采用混合方法，结合了与主要相关利益者的对话、技术审查和跨职能检验。主要资料收集包括对包装营运经理、供应链主管、品质和法规专家以及设备供应商进行结构化访谈，以确定营运限制、验证方法和新的投资重点。次要分析参考了法规指南、关税和技术标准，以评估合规性对材料和工艺的影响。设备和材料规格为自动化和材料权衡提供了技术框架。

将策略要务与采购韧性、模组化自动化、序列化和区域能力协调等重点相结合，以确保长期的营运和商业性优势。

总之，合约包装产业正处于一个转折点，日益复杂的监管环境、波动的关税以及技术的进步正在共同重塑竞争优势。那些能够透过策略采购和落地成本建模积极应对投入成本波动、投资模组化自动化以提高品质和产量、并整合端到端序列化和追踪系统的企业，将更有能力满足生物製药开发商、品牌所有者和学名药生产商不断变化的需求。此外，根据管理体制和客户细分情况，按地区优化产能部署的策略将有助于降低风险并创造成长机会。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 为确保符合全球药物监管法规，应越来越多地采用先进的序列化和可追溯性技术。
  • 製药业的ESG（环境、社会和治理）措施正在推动对永续和可回收包装材料的需求。
  • 拓展针对罕见疾病生物製药和药物小批量生产的个人化医疗包装服务
  • 在低温运输产品的合约包装生产线中整合物联网感测器和即时监控解决方案
  • 投资自动化和机器人技术，以优化药品包装效率并降低营运成本。
  • 对于高风险药品和鸦片类药物而言，儿童安全防篡改包装变得越来越重要。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依自动化程度分類的药品合约包装市场

  • 自动包装
    • 机器人系统
    • 半自动系统
  • 手工包装

9. 按最终用户分類的药品合约包装市场

  • 生技公司
    • 生物製药开发公司
    • 生物相似药生产商
  • 品牌拥有者
    • 跨国企业
    • 当地公司
  • 非专利公司
    • 本地非专利公司

第十章：按材料类型分類的药品合约包装市场

  • 玻璃
    • I 型玻璃
    • II 型玻璃
    • 第三型玻璃
  • 金属
    • 铝
    • 钢
  • 塑胶
    • 高密度聚苯乙烯
    • 聚对苯二甲酸乙二酯
    • 聚氯乙烯

第十一章 依包装类型分類的药品合约包装市场

  • 初级包装
    • 安瓿
    • 泡壳包装
    • 管瓶
  • 二级包装
    • 纸盒
    • 托盘
  • 三级包装
    • 调色盘
    • 收缩膜

第十二章 依剂型分類的药品合约包装市场

  • 液体
    • 注射
    • 口服液
  • 半固态
    • 奶油
    • 凝胶
    • 软膏
  • 固态剂型
    • 胶囊
    • 药片

第十三章：按服务类型分類的药品合约包装市场

  • 设计与开发
    • 概念设计
    • 原型
  • 灌装/密封
    • 液体填充
    • 粉末填充
  • 标籤
    • 压力敏感
    • 液体胶
  • 序列化和追踪
    • 条码
    • RFID标籤

第十四章 各地区医药合约包装市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 医药合约包装市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国药品合约包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Catalent Pharma Solutions, LLC
    • PCI Pharma Services, Inc.
    • Sharp Packaging Services, Inc.
    • Aenova Holding GmbH
    • Recipharm AB
    • Almac Pharma Services Ltd
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • CordenPharma International Corp.
    • Siegried Holding AG
    • Ajinomoto Bio-Pharma Services, Inc.

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 为确保符合全球药物监管法规，应越来越多地采用先进的序列化和可追溯性技术。
  • 製药业的ESG（环境、社会和治理）措施正在推动对永续和可回收包装材料的需求。
  • 拓展针对罕见疾病生物製药和药物小批量生产的个人化医疗包装服务
  • 在低温运输产品的合约包装生产线中整合物联网感测器和即时监控解决方案
  • 投资自动化和机器人技术，以优化药品包装效率并降低营运成本。
  • 对于高风险药品和鸦片类药物而言，儿童安全防篡改包装变得越来越重要。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依自动化程度分類的药品合约包装市场

  • 自动包装
    • 机器人系统
    • 半自动系统
  • 手工包装

9. 按最终用户分類的药品合约包装市场

  • 生技公司
    • 生物製药开发公司
    • 生物相似药生产商
  • 品牌拥有者
    • 跨国企业
    • 当地公司
  • 非专利公司
    • 本地非专利公司

第十章：按材料类型分類的药品合约包装市场

  • 玻璃
    • I 型玻璃
    • II 型玻璃
    • 第三型玻璃
  • 金属
    • 铝
    • 钢
  • 塑胶
    • 高密度聚苯乙烯
    • 聚对苯二甲酸乙二酯
    • 聚氯乙烯

第十一章 依包装类型分類的药品合约包装市场

  • 初级包装
    • 安瓿
    • 泡壳包装
    • 管瓶
  • 二级包装
    • 纸盒
    • 托盘
  • 三级包装
    • 调色盘
    • 收缩膜

第十二章 依剂型分類的药品合约包装市场

  • 液体
    • 注射
    • 口服液
  • 半固态
    • 奶油
    • 凝胶
    • 软膏
  • 固态剂型
    • 胶囊
    • 药片

第十三章：按服务类型分類的药品合约包装市场

  • 设计与开发
    • 概念设计
    • 原型
  • 灌装/密封
    • 液体填充
    • 粉末填充
  • 标籤
    • 压力敏感
    • 液体胶
  • 序列化和追踪
    • 条码
    • RFID标籤

第十四章 各地区医药合约包装市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 医药合约包装市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国药品合约包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Catalent Pharma Solutions, LLC
    • PCI Pharma Services, Inc.
    • Sharp Packaging Services, Inc.
    • Aenova Holding GmbH
    • Recipharm AB
    • Almac Pharma Services Ltd
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • CordenPharma International Corp.
    • Siegried Holding AG
    • Ajinomoto Bio-Pharma Services, Inc.
Product Code: MRR-2A0283E25592

The Pharmaceutical Contract Packaging Market is projected to grow by USD 70.49 billion at a CAGR of 9.21% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 34.82 billion
Estimated Year [2025] USD 38.10 billion
Forecast Year [2032] USD 70.49 billion
CAGR (%) 9.21%

Framing the evolving strategic role of contract packaging as a mission-critical enabler of product integrity, compliance, and commercial differentiation across pharmaceutical portfolios

The pharmaceutical contract packaging sector occupies a pivotal position at the intersection of clinical supply continuity, brand protection, and regulatory compliance. Recent years have seen packaging evolve from a commoditized service to a strategic enabler of product integrity, patient safety, and market differentiation. As manufacturers grapple with increasingly complex biologics, combination products, and diversified global routes to market, packaging partners must deliver precision, traceability, and flexibility across a widening array of materials and formats.

Consequently, organizations that lead in integrating technology, quality systems, and supply chain resilience will set new performance baselines. This introduction frames the regulatory, operational, and strategic context that shapes current decision-making for contract packagers, brand owners, generics and biotechs alike. It highlights the imperative to adopt modular capabilities that accommodate diverse dosage forms, advanced serialization requirements, and evolving expectations around sustainability without compromising speed to market or compliance.

Exploring how automation, digital traceability, material innovation, and changing end-user demands are converging to redefine contract packaging strategies and capabilities

Across the pharmaceutical packaging landscape, transformative shifts are remaking competitive dynamics and operational priorities. Advances in automation, from fully robotic lines to semi-automated cells, are enabling higher throughput while reducing human error and improving contamination control. At the same time, digitalization and serialization technologies are reshaping traceability capabilities, enabling real-time visibility from filling to distribution and supporting stricter regulatory expectations for anti-counterfeiting and supply chain transparency.

Parallel to technological change, end-user demands are fragmenting. Biopharma innovators and biosimilars manufacturers require specialized sterile handling and cold-chain-compatible packaging, multinational brand owners seek consistent global labeling and branding controls, and regional and local generics prioritize cost efficiency and speed. Material innovation is also influencing design choices: glass types and metal alloys are being balanced against high-performance plastics according to stability, regulatory tolerance, and sustainability targets. Finally, service models are shifting toward integrated offerings that bundle design and development, filling, labeling, and serialization to provide single-source accountability and faster product commercialization timelines.

Assessing the multifaceted consequences of tariff developments through 2025 on input costs, sourcing strategies, compliance burdens, and capital allocation for packaging operations

The cumulative impact of tariff measures announced or implemented through 2025 has created a new layer of cost and strategic complexity for contract packaging operations. Increased duties on imported raw materials such as glass, aluminum, steel and certain plastics have elevated input costs and compelled packaging organizations to reassess sourcing strategies and supplier relationships. In response, many organizations accelerated dual-sourcing initiatives, shifted procurement toward nearer-shore suppliers, and intensified negotiations to preserve margin while maintaining compliance with regulatory material specifications.

These tariff-driven pressures have also influenced investment priorities. Firms that face sustained input-cost volatility have accelerated automation and efficiency programs to reduce unit labor cost and improve yield. At the same time, the reconfiguration of supply chains to avoid tariff exposure has led to higher inventory buffers in some regions and the selective relocation of critical production steps. Compliance considerations, including duty classification and documentation under the Harmonized Tariff Schedule and evolving trade enforcement practices, have obligated contract packagers to tighten import/export controls and to incorporate tariff risk into commercial terms. Consequently, procurement teams and commercial negotiators are increasingly embedding tariff clauses and landed-cost modeling into supplier contracts, while regulatory and quality teams work in parallel to ensure material substitutions meet stability and pharmacopoeial requirements.

Comprehensive segmentation-driven insights revealing how automation, end-user profiles, material choices, packaging formats, dosage forms, and service types determine strategic priorities and operational design

Segmentation analysis illuminates where value and risk concentrate across the contract packaging ecosystem, and understanding these strata helps leaders prioritize investments and partnerships. Evaluating automation level reveals two distinct operational cohorts: manual packaging operations that remain critical for certain low-volume or highly customized product lines, and automated packaging that delivers scale and consistency. Within automation, robotic systems offer the highest repeatability and sterile-zone benefits for injectable and sensitive formats, while semi-automated systems provide a balance of flexibility and cost for medium-volume runs and secondary packaging tasks.

End-user segmentation demonstrates how customer requirements drive service design. Biotech companies-differentiated between biopharma innovators and biosimilars manufacturers-demand high-touch, sterile handling and often bespoke packaging development. Brand owners, split into multinational companies and regional companies, require consistent labeling, global regulatory harmonization and scalable secondary and tertiary packaging solutions. Generic companies, represented by local generics, emphasize cost efficiency and rapid turnarounds. Material-type segmentation further refines operational choices: glass options such as Type I, II and III glass determine chemical inertness and shelf-life expectations; metal substrates, including aluminum and steel, provide barrier and mechanical strength for certain formats; and plastics-from high density polyethylene to polyethylene terephthalate and polyvinyl chloride-offer trade-offs among cost, barrier properties and sustainability profiles. Packaging type segmentation distinguishes primary formats like ampoules, blister packs and vials from secondary formats such as cartons and trays and from tertiary solutions including pallets and shrink wrap, each demanding different handling, labeling and unitization processes. Dosage-form segmentation separates liquid dosage into injectables and oral solutions, semi-solid forms into creams, gels and ointments, and solid dosage into capsules and tablets, which in turn determine filling technology, contaminant control, and packaging material compatibility. Service-type segmentation encapsulates design and development activities-concept design and prototyping-alongside filling and sealing for liquid and powder, labeling approaches that range from pressure sensitive to wet glue, and serialization and track and trace capabilities that include barcoding and RFID tagging, all of which together form end-to-end service bundles that customers expect when outsourcing packaging.

Regional differentiation and capacity prioritization across the Americas, Europe Middle East & Africa, and Asia-Pacific to align capabilities with regulatory and commercial realities

Regional dynamics are shaping where investment and capacity expansion will deliver the greatest strategic value, and a differentiated regional approach is necessary for resilient operations. In the Americas, integrated supply chains, large biologics pipelines, and established regulatory frameworks create demand for advanced sterile fill-finish capabilities, serialization compliance and robust secondary and tertiary logistics. This region also presents opportunities for near-shore sourcing strategies that mitigate tariff exposure and support rapid response to market demand.

Across Europe, the Middle East & Africa, regulatory harmonization and dense cross-border trade require flexible labeling and multilingual documentation management alongside sustainable packaging solutions that meet stringent environmental mandates. Companies operating here must balance centralized volume consolidation with localized packaging adaptations. In the Asia-Pacific region, fast-growing contract development and manufacturing ecosystems, combined with varied regulatory environments and competitive material supply chains, make cost-effective automation, scalable secondary packaging and rapid format changeovers essential. Each region therefore demands tailored commercial propositions, local supplier networks, and compliance architectures that align with regional regulatory regimes, logistics constraints, and customer expectations.

Competitive dynamics driven by strategic partnerships, vertical integration, specialization, and investments in quality systems and automation to capture diverse pharmaceutical packaging demands

Key company behaviors indicate consolidation, strategic partnerships, and capability specialization as dominant themes. Contract packaging providers are increasingly forming alliances with material suppliers, equipment vendors and technology firms to accelerate access to advanced filling, labeling and serialization capabilities while controlling capital intensity. Such partnerships also enable more rapid deployment of validated lines for biologics and complex dosage forms. Meanwhile, some firms pursue vertical integration to capture higher-margin services such as design and development or serialization and track-and-trace, while others focus on niche specialization-sterile injectables, cold-chain handling, or high-volume blister operations-to preserve operational efficiency.

Market leaders distinguish themselves through repeatable quality systems, regulatory expertise and robust validation protocols that reduce time-to-market for customers. They invest in workforce training to operate and maintain robotic and semi-automated cells, and they implement advanced analytics to monitor process performance, yield, and compliance. Emerging competitors differentiate on speed and price, leveraging modular lines and flexible staffing models to win smaller or regional contracts. Overall, competitive advantage accrues to companies that combine technical depth with commercial agility and the ability to deliver integrated service suites across design, fill-finish, labeling, and serialization.

Actionable dual-track recommendations to optimize landed cost, accelerate serialization, and sequence automation investments while expanding regional capability footprints and sustainability initiatives

Industry leaders should pursue a dual-track strategy that balances near-term resilience with long-term capability building. In the near term, prioritize landed-cost optimization by redesigning supplier contracts to include tariff contingency clauses, increasing dual-sourcing where feasible, and conducting material requalification programs that evaluate Type I glass alternatives and high-performance plastics for stability equivalence. Concurrently, accelerate the roll-out of serialization and track-and-trace systems that not only meet regulatory mandates but also provide operational visibility to reduce recalls and streamline returns.

For longer-term competitiveness, invest in a phased automation roadmap that sequences robotic systems for sterile and high-precision tasks while deploying semi-automated solutions for secondary packaging to preserve flexibility. Integrate design and prototyping capabilities to shorten development cycles and partner with equipment vendors on validation-ready solutions to reduce qualification timelines. Strengthen regional footprints by aligning capabilities to local regulatory realities and customer segments, and embed sustainability targets into material selection and tertiary unitization strategies. Finally, build a commercial model that offers modular service bundles-design and development, filling and sealing, labeling, serialization and track-and-trace-to capture a broader share of customer spend while providing single-source accountability for speed and quality.

Robust mixed-methods research design integrating primary industry interviews, regulatory and technical review, scenario mapping, and iterative expert validation to ensure actionable and defensible insights

This research employed a mixed-methods approach combining primary stakeholder engagement with secondary technical review and cross-functional triangulation. Primary data collection included structured interviews with packaging operations leaders, supply chain executives, quality and regulatory experts, and equipment providers to surface operational constraints, validation practices and emerging investment priorities. Secondary analysis drew from regulatory guidance, tariff schedules, and technical standards to assess compliance implications for materials and processes, while equipment and materials specifications provided the technical framing for automation and material trade-offs.

Analytical methods included scenario mapping to evaluate tariff-induced supply chain reconfigurations, capability gap analysis to identify where investments in automation and serialization yield the greatest operational returns, and segmentation analysis to align service offerings with customer types, dosage forms and packaging formats. Findings were validated through iterative expert review and by reconciling operational anecdotes with documented regulatory and technical requirements to ensure robustness. This methodology supports actionable insights while maintaining transparency on assumptions and the limitations inherent in rapidly changing trade and regulatory environments.

Synthesis of strategic imperatives emphasizing sourcing resilience, modular automation, serialization, and regional capability alignment to secure long-term operational and commercial advantage

In conclusion, the contract packaging sector stands at an inflection point where regulatory complexity, tariff dynamics, and technological advancement collectively redefine competitive advantage. Organizations that proactively address input-cost volatility through strategic sourcing and landed-cost modeling, that invest in modular automation to improve quality and throughput, and that embed end-to-end serialization and track-and-trace will be best positioned to serve the evolving needs of biopharma innovators, brand owners and generics manufacturers. Moreover, a regionally nuanced strategy that aligns capability deployment with regulatory regimes and customer segmentation will mitigate risk and unlock growth opportunities.

The path forward requires a disciplined focus on validated processes, workforce capability, and strategic partnerships that accelerate access to critical technologies and materials. By translating these insights into prioritized investments and operational changes, contract packagers and their customers can strengthen resilience, accelerate commercialization timelines, and protect product integrity across diverse markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of advanced serialization and traceability technologies to ensure compliance with global pharmacovigilance regulations
  • 5.2. Growing demand for sustainable and recyclable packaging materials driven by pharmaceutical industry ESG commitments
  • 5.3. Expansion of personalized medicine packaging services catering to small-batch biologics and orphan drug therapies
  • 5.4. Integration of IoT sensors and real-time monitoring solutions in contract packaging lines for cold chain products
  • 5.5. Investment in automation and robotics to optimize pharmaceutical packaging throughput and reduce operational costs
  • 5.6. Rising emphasis on child-resistant and tamper-evident packaging for high-risk medications and opioid products

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Contract Packaging Market, by Automation Level

  • 8.1. Automated Packaging
    • 8.1.1. Robotic Systems
    • 8.1.2. Semi Automated Systems
  • 8.2. Manual Packaging

9. Pharmaceutical Contract Packaging Market, by End User

  • 9.1. Biotech Companies
    • 9.1.1. Biopharma Innovators
    • 9.1.2. Biosimilars Manufacturers
  • 9.2. Brand Owners
    • 9.2.1. Multinational Companies
    • 9.2.2. Regional Companies
  • 9.3. Generic Companies
    • 9.3.1. Local Generics

10. Pharmaceutical Contract Packaging Market, by Material Type

  • 10.1. Glass
    • 10.1.1. Type I Glass
    • 10.1.2. Type II Glass
    • 10.1.3. Type III Glass
  • 10.2. Metal
    • 10.2.1. Aluminum
    • 10.2.2. Steel
  • 10.3. Plastic
    • 10.3.1. High Density Polyethylene
    • 10.3.2. Polyethylene Terephthalate
    • 10.3.3. Polyvinyl Chloride

11. Pharmaceutical Contract Packaging Market, by Packaging Type

  • 11.1. Primary
    • 11.1.1. Ampoules
    • 11.1.2. Blister Packs
    • 11.1.3. Vials
  • 11.2. Secondary
    • 11.2.1. Cartons
    • 11.2.2. Trays
  • 11.3. Tertiary
    • 11.3.1. Pallets
    • 11.3.2. Shrink Wrap

12. Pharmaceutical Contract Packaging Market, by Dosage Form

  • 12.1. Liquid Dosage
    • 12.1.1. Injectable
    • 12.1.2. Oral Solutions
  • 12.2. Semi Solid
    • 12.2.1. Creams
    • 12.2.2. Gels
    • 12.2.3. Ointments
  • 12.3. Solid Dosage
    • 12.3.1. Capsules
    • 12.3.2. Tablets

13. Pharmaceutical Contract Packaging Market, by Service Type

  • 13.1. Design & Development
    • 13.1.1. Concept Design
    • 13.1.2. Prototyping
  • 13.2. Filling & Sealing
    • 13.2.1. Liquid Filling
    • 13.2.2. Powder Filling
  • 13.3. Labeling
    • 13.3.1. Pressure Sensitive
    • 13.3.2. Wet Glue
  • 13.4. Serialization & Track & Trace
    • 13.4.1. Barcoding
    • 13.4.2. RFID Tagging

14. Pharmaceutical Contract Packaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pharmaceutical Contract Packaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pharmaceutical Contract Packaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Catalent Pharma Solutions, LLC
    • 17.3.2. PCI Pharma Services, Inc.
    • 17.3.3. Sharp Packaging Services, Inc.
    • 17.3.4. Aenova Holding GmbH
    • 17.3.5. Recipharm AB
    • 17.3.6. Almac Pharma Services Ltd
    • 17.3.7. Vetter Pharma-Fertigung GmbH & Co. KG
    • 17.3.8. CordenPharma International Corp.
    • 17.3.9. Siegried Holding AG
    • 17.3.10. Ajinomoto Bio-Pharma Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY,